Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
09 2021
Historique:
received: 14 08 2020
revised: 23 03 2021
accepted: 01 04 2021
pubmed: 4 5 2021
medline: 26 8 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Autosomal recessive polycystic kidney disease (ARPKD) is a severe disease of early childhood that is clinically characterized by fibrocystic changes of the kidneys and the liver. The main cause of ARPKD are variants in the PKHD1 gene encoding the large transmembrane protein fibrocystin. The mechanisms underlying the observed clinical heterogeneity in ARPKD remain incompletely understood, partly due to the fact that genotype-phenotype correlations have been limited to the association of biallelic null variants in PKHD1 with the most severe phenotypes. In this observational study we analyzed a deep clinical dataset of 304 patients with ARPKD from two independent cohorts and identified novel genotype-phenotype correlations during childhood and adolescence. Biallelic null variants frequently show severe courses. Additionally, our data suggest that the affected region in PKHD1 is important in determining the phenotype. Patients with two missense variants affecting amino acids 709-1837 of fibrocystin or a missense variant in this region and a null variant less frequently developed chronic kidney failure, and patients with missense variants affecting amino acids 1838-2624 showed better hepatic outcome. Variants affecting amino acids 2625-4074 of fibrocystin were associated with poorer hepatic outcome. Thus, our data expand the understanding of genotype-phenotype correlations in pediatric ARPKD patients and can lay the foundation for more precise and personalized counselling and treatment approaches.

Identifiants

pubmed: 33940108
pii: S0085-2538(21)00459-2
doi: 10.1016/j.kint.2021.04.019
pii:
doi:

Substances chimiques

PKHD1 protein, human 0
Receptors, Cell Surface 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-659

Investigateurs

Loai Akram Eid (LA)
Klaus Arbeiter (K)
Nathalie Godefroid (N)
Jacques Lombet (J)
Aurélie De Mul (A)
Markus Feldkoetter (M)
Jakub Zieg (J)
Franziska Grundmann (F)
Matthias Galiano (M)
Björn Buchholz (B)
Anja Buescher (A)
Karsten Häffner (K)
Oliver Gross (O)
Ludwig Patzer (L)
Jun Oh (J)
Dieter Haffner (D)
Wanja Bernhardt (W)
Susanne Schaefer (S)
Simone Wygoda (S)
Jan Halbritter (J)
Ute Derichs (U)
Günter Klaus (G)
Felix Lechner (F)
Sabine Ponsel (S)
Jens König (J)
Hagen Staude (H)
Donald Wurm (D)
Martin Bald (M)
Michaela Gessner (M)
Neveen A Soliman (NA)
Gema Ariceta (G)
Juan David Gonzalez Rodriguez (JD)
Francisco de la Cerda Ojeda (FC)
Jerome Harambat (J)
Denis Morin (D)
Claire Dossier (C)
Guillaume Dorval (G)
Rukshana Shroff (R)
Stella Stabouli (S)
Nakysa Hooman (N)
Francesca Mencarelli (F)
William Morello (W)
Germana Longo (G)
Francesco Emma (F)
Augustina Jankauskiene (A)
Katarzyna Taranta-Janusz (K)
Ilona Zagozdzon (I)
Katarzyna Zachwieja (K)
Malgorzata Stanczyk (M)
Beata Bienias (B)
Mieczyslaw Litwin (M)
Aurelia Morawiec-Knysak (A)
Alberto Caldas Afonso (AC)
Oliver Dunand (O)
Andreea Rachisan (A)
Gordana Miloševski-Lomić (G)
Svetlana Papizh (S)
Rina Rus (R)
Houweyda Jilani (H)
Bahriye Atmis (B)
Ali Duzova (A)
Alper Soylu (A)
Cengiz Candan (C)
Salim Caliskan (S)
Alev Yilmaz (A)
İbrahim Gökce (İ)
Nurver Akinci (N)
Sevgi Mir (S)
Ismail Dursun (I)
Yilmaz Tabel (Y)
Hulya Nalcacioglu (H)

Informations de copyright

Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Kathrin Burgmaier (K)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany.

Leonie Brinker (L)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany.

Florian Erger (F)

Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Institute of Human Genetics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

Bodo B Beck (BB)

Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Institute of Human Genetics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

Marcus R Benz (MR)

Pediatric Nephrology Dachau, Dachau, Germany.

Carsten Bergmann (C)

Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany; Renal Division, Department of Medicine, University Freiburg Medical Center, Freiburg, Germany.

Olivia Boyer (O)

Department of Pediatric Nephrology and Kidney Transplantation, Necker Hospital, APHP, Paris University, Paris, France.

Laure Collard (L)

Reference centre pediatric nephrology, Clinique de l'Espérance, Montegnee, Belgium.

Claudia Dafinger (C)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

Marc Fila (M)

Pediatric Nephrology Unit, CHU Arnaud de Villeneuve-Université de Montpellier, Montpellier, France.

Claudia Kowalewska (C)

Department of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.

Bärbel Lange-Sperandio (B)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.

Laura Massella (L)

Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital - IRCCS, Rome, Italy.

Antonio Mastrangelo (A)

Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Djalila Mekahli (D)

PKD Research Group, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.

Monika Miklaszewska (M)

Department of Pediatric Nephrology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.

Nadina Ortiz-Bruechle (N)

Institute of Human Genetics, RWTH University Hospital Aachen, Aachen, Germany.

Ludwig Patzer (L)

Department of Pediatrics, Children's Hospital St. Elisabeth and St. Barbara, Halle (Saale), Germany.

Larisa Prikhodina (L)

Department of Inherited and Acquired Kidney Diseases, Research Clinical Institute for Pediatrics n.a. acad. Y. E. Veltishev, Pirogov Russian National Research Medical University, Moscow, Russia.

Bruno Ranchin (B)

Pediatric Nephrology Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Centre de référence maladies rénales rares, Bron, France.

Nadejda Ranguelov (N)

Department of Pediatrics, Université Catholique de Louvain Medical School, Saint-Luc Academic Hospital, Brussels, Belgium.

Raphael Schild (R)

University Children's Hospital, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

Tomas Seeman (T)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany; Department of Pediatrics, University Hospital Motol, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic.

Lale Sever (L)

Department of Pediatric Nephrology, Cerrahpaşa School of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.

Przemyslaw Sikora (P)

Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.

Maria Szczepanska (M)

Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.

Ana Teixeira (A)

Centro Materno-Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal.

Julia Thumfart (J)

Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin Berlin, Berlin, Germany.

Barbara Uetz (B)

KfH Center of Pediatric Nephrology, Children's Hospital Munich Schwabing, Munich, Germany.

Lutz Thorsten Weber (LT)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany.

Elke Wühl (E)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Klaus Zerres (K)

Institute of Human Genetics, RWTH University Hospital Aachen, Aachen, Germany.

Jörg Dötsch (J)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany.

Franz Schaefer (F)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Max Christoph Liebau (MC)

Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. Electronic address: max.liebau@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH